CoChat

Delivery Strategies for Immune Checkpoint Blockade

Chen, Qian, Wang, Chao, Chen, Guojun, Hu, Quanyin, Gu, Zhen · 2018 · Advanced Healthcare Materials

The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.

Abstract

Immune checkpoint blockade, which blocks the regulatory pathways that express on immune cells to improve antitumor immunological responses, is becoming one of the most promising approaches for antitumor therapy. This therapy has achieved important clinical advancement and provided a new opportunity against a variety of cancers. However, limitations of checkpoint inhibitors application, including the risk of autoimmune disease, low objective response rates, and high cost, still largely affect their broad applications in patients. Therefore, it is desirable to seek effective delivery methods to further enhance the therapeutic efficacy and reduce drawbacks of immune checkpoint blockade. This brief review summarizes strategies to increase the antitumor immunity, including the local and targeted delivery of checkpoint inhibitors, and a combination of different checkpoint inhibitors or with other therapeutic treatments.

Overview

Integrity signals

Registry

Crossref · 10.1002/adhm.201800424

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 94 references

Research works printed but not linked: 1

  1. Qi Q., 2016, Cancer ‐ Am. Cancer Soc., 122, 2158

Cited by

See all 92

Metadata

Authors
Chen, Q., Wang, C., Chen, G., Hu, Q., & Gu, Z.
Affiliations
University of North Carolina at Chapel Hill (US)
Corresponding author
Gu, Zhen
Venue
Advanced Healthcare Materials
Publisher
Wiley
Published
2018-07-05
Volume
7
Issue
20
Pages
e1800424-e1800424
ISSN
  • 2192-2640 (ISSN-L)
  • 2192-2659
OpenAlex
W2861806171
Cited by
90
References
94
Citations by year
2026: 2 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 16 · 2021: 16 · 2020: 12 · 2019: 16 · 2018: 5
FWCI
1.28
Type
journal article
Language
en
Open access
closed
Locations
  • Advanced Healthcare Materials (publishedVersion)
  • PubMed (publishedVersion)
Funders
Alfred P. Sloan Foundation
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
immune checkpoint blockade, drug delivery methods, targeted drug delivery, local drug delivery, combination therapy, antitumor immunity, immune checkpoint inhibitors, autoimmune adverse effects, cancer immunotherapy
MeSH terms
Autoimmune Diseases, Humans, Immunotherapy, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.